These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29623561)

  • 41. Natural killer cells in liver diseases.
    Zheng M; Sun H; Tian Z
    Front Med; 2018 Jun; 12(3):269-279. PubMed ID: 29675689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.
    Chen Y; Tian Z
    Cell Mol Immunol; 2021 Jan; 18(1):57-72. PubMed ID: 33041339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.
    Faure-Dupuy S; Lucifora J; Durantel D
    Viruses; 2017 Apr; 9(5):. PubMed ID: 28452930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Notch 1 and Notch 2 synergistically regulate the differentiation and function of invariant NKT cells.
    Oh SJ; Ahn S; Jin YH; Ishifune C; Kim JH; Yasutomo K; Chung DH
    J Leukoc Biol; 2015 Nov; 98(5):781-9. PubMed ID: 26188077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of SLAM-associated protein in the pathogenesis of autoimmune diseases and immunological disorders.
    Furukawa H; Tohma S; Kitazawa H; Komori H; Nose M; Ono M
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):37-44. PubMed ID: 20049647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice.
    Ishikawa S; Ikejima K; Yamagata H; Aoyama T; Kon K; Arai K; Takeda K; Watanabe S
    J Hepatol; 2011 Jun; 54(6):1195-204. PubMed ID: 21145835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural Killer T (NKT) Cells in Autoimmune Hepatitis: Current Evidence from Basic and Clinical Research.
    Poddighe D; Maulenkul T; Zhubanova G; Akhmaldtinova L; Dossybayeva K
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishment of a vascular endothelial cell-reactive type II NKT cell clone from a rat model of autoimmune vasculitis.
    Iinuma C; Waki M; Kawakami A; Yamaguchi M; Tomaru U; Sasaki N; Masuda S; Matsui Y; Iwasaki S; Baba T; Kasahara M; Yoshiki T; Paletta D; Herrmann T; Ishizu A
    Int Immunol; 2015 Feb; 27(2):105-14. PubMed ID: 25239132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoregulation of autoimmunity by natural killer T cells.
    Linsen L; Somers V; Stinissen P
    Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NK and NKT cells in liver injury and fibrosis.
    Notas G; Kisseleva T; Brenner D
    Clin Immunol; 2009 Jan; 130(1):16-26. PubMed ID: 18823822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thioredoxin binding protein 2 modulates natural killer T cell-dependent innate immunity in the liver: possible link to lipid metabolism.
    Okuyama H; Yoshida T; Son A; Oka S; Wang D; Nakayama R; Masutani H; Nakamura H; Nabeshima Y; Yodoi J
    Antioxid Redox Signal; 2009 Oct; 11(10):2585-93. PubMed ID: 19619006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural Killer T Cells in Various Mouse Models of Hepatitis.
    Guan J; Wang G; Yang Q; Chen C; Deng J; Gu X; Zhu H
    Biomed Res Int; 2021; 2021():1782765. PubMed ID: 33506011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL13Rα2 expression identifies tissue-resident IL-22-producing PLZF
    Paquin-Proulx D; Greenspun BC; Pasquet L; Strunz B; Aleman S; Falconer K; Terabe M; Berzofsky JA; Sandberg JK; Melum E; Nixon DF; Björkström NK
    Eur J Immunol; 2018 Aug; 48(8):1329-1335. PubMed ID: 29677387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Innate-like T lymphocytes in chronic liver disease.
    Papanastasatou M; Verykokakis M
    Front Immunol; 2023; 14():1114605. PubMed ID: 37006304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. γδ T cells in liver diseases.
    Wang X; Tian Z
    Front Med; 2018 Jun; 12(3):262-268. PubMed ID: 29441440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunological aspect of liver and liver diseases].
    Onji M
    Nihon Shokakibyo Gakkai Zasshi; 2004 Feb; 101(2):146-54. PubMed ID: 15011438
    [No Abstract]   [Full Text] [Related]  

  • 57. Immune-mediated liver injury.
    Eksteen B; Afford SC; Wigmore SJ; Holt AP; Adams DH
    Semin Liver Dis; 2007 Nov; 27(4):351-66. PubMed ID: 17979072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of natural killer cells in liver inflammation.
    Highton AJ; Schuster IS; Degli-Esposti MA; Altfeld M
    Semin Immunopathol; 2021 Aug; 43(4):519-533. PubMed ID: 34230995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of altered immune cells in liver diseases: a review.
    Wahid B; Ali A; Rafique S; Saleem K; Waqar M; Wasim M; Idrees M
    Gastroenterol Hepatol; 2018; 41(6):377-388. PubMed ID: 29605453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The emerging role of mast cells in liver disease.
    Jarido V; Kennedy L; Hargrove L; Demieville J; Thomson J; Stephenson K; Francis H
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G89-G101. PubMed ID: 28473331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.